FLACU
Get informed when a big investor buys or sells
+ Follow| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-375,545.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.55 |
| Beta | 0 |
| Outstanding Shares | 14,301,000 |
| P/E Ratio | 17.99 |
|---|---|
| PEG | -3.46 |
| Price to Sales | - |
| Price to Book Ratio | 1.19 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.07 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Frazier Lifesciences Acquisition Corporation, sponsored by a Cayman Islands affiliate of Frazier Life Sciences X, L.P., is a newly incorporated blank check company, incorporated as a Cayman Islands exempted company for the purpose of eff...